文献速递病毒性肝炎

治疗未启动者中极低丙型肝炎病毒载量的流行率与抗原检测影响

Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?
PubMed 文献 · Clin Infect Dis · 2020-01-01

基于瑞士丙型肝炎队列2533例治疗未启动者,5.3%存在极低病毒载量(HCV RNA≤3000 IU/mL)。极低载量者肝硬化与死亡率与无此情况者相当,但抗原检测仅33%样本呈反应性,提示抗原筛查可能漏诊部分严重肝病患者。

要点

  • 治疗未启动者中极低病毒载量(≤3000 IU/mL)占5.3%。
  • 极低载量样本抗原检测仅33%呈反应性,存在漏诊风险。
  • 合并肝硬化者均有过量饮酒或免疫抑制,抗原筛查可能漏诊严重肝病。

核心结论

  • 极低HCV RNA载量频率较低,但抗原检测对这类样本敏感性不足,可能漏诊部分严重肝病患者。

研究设计与样本

  • 瑞士丙型肝炎队列研究,纳入2533例治疗未启动且具备定量HCV RNA结果的参与者,采用逻辑回归分析极低病毒载量的预测因素。

主要发现

  • 133例(5.3%)存在极低病毒载量(HCV RNA≤3000 IU/mL)。
  • 年龄18-40岁、女性、合并HIV感染与极低病毒载量相关。
  • 72例有极低载量后病毒载量数据者中,14%仍为极低载量,17%发生自发病毒清除。
  • 极低载量者与无此情况者的肝硬化和死亡率相当;24例极低载量合并肝硬化者均有过量饮酒或免疫抑制。
  • 极低载量样本中33%抗原检测呈反应性。

临床怎么用

  • 抗原检测筛查HCV时需认识到极低病毒载量者可能被漏检,尤其合并免疫抑制或肝硬化者。

局限性

  • 极低载量后病毒载量数据仅72例,随访样本有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis C virus (HCV) antigen testing is less expensive than quantitative reverse-transcription polymerase chain reaction but has lower sensitivity for very low viral load (VLVL; HCV RNA ≤3000 IU/mL). Currently the benefits of antigen testing for screening are discussed, but data on prevalence and outcomes of persons with VLVL are scarce. METHODS: We assessed prevalence and predictors of VLVL by logistic regression in treatment-naive participants in the Swiss Hepatitis C Cohort Study. We analyzed if the last viral load after VLVL was low, compared cirrhosis and mortality in persons with and without VLVL, and evaluated the number of samples with VLVL that were reactive by antigen testing. RESULTS: We included 2533 treatment-naive persons with available quantitative HCV RNA testing results. Overall, 133 persons (5.3%) had a VLVL. Age 18-40 years, female sex, and human immunodeficiency virus coinfection were associated with VLVL. Of 72 persons with a viral load available after VLVL, 14% had a VLVL and 17% had spontaneous viral clearance. The prevalence and incidence of cirrhosis and mortality were comparable in persons with and without VLVL; all 24 persons with VLVL and cirrhosis had excessive alcohol consumption or immunosuppression. Overall, 33% of samples with VLVL were reactive by antigen testing. CONCLUSIONS: The frequency of VLVL was low. Among the persons who would probably be missed by antigen screening, some had a favorable disease course, but some had immunosuppression and liver cirrhosis. The benefit of HCV antigen testing for screening may be limited by the risk of missing patients with severe liver disease.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bertisch B, Brezzi M, Negro F, et al. Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing? Clin Infect Dis. 2020. PMID: 30943286. doi:10.1093/cid/ciz270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。